In vitro combination of PNU-140690, a human immunodeficiency virus type 1 protease inhibitor, with ritonavir against ritonavir-sensitive and -resistant clinical isolates.

Samankaltaisia teoksia

• Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor.
  Tekijä: Poppe, S M, et al.
  Julkaistu: (1997)
• Susceptibility to PNU-140690 (Tipranavir) of Human Immunodeficiency Virus Type 1 Isolates Derived from Patients with Multidrug Resistance to Other Protease Inhibitors
  Tekijä: Rusconi, Stefano, et al.
  Julkaistu: (2000)
• Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir.
  Tekijä: Kempf, D J, et al.
  Julkaistu: (1997)
• The human immunodeficiency virus protease inhibitor ritonavir is potentially active against urological malignancies
  Tekijä: Sato, Akinori
  Julkaistu: (2015)
• Activities of the human immunodeficiency virus type 1 (HIV-1) protease inhibitor nelfinavir mesylate in combination with reverse transcriptase and protease inhibitors against acute HIV-1 infection in vitro.
  Tekijä: Patick, A K, et al.
  Julkaistu: (1997)